These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3133915)

  • 1. [Dynamics of the shedding of bacterial and ultrafine forms of mycobacteria during the chemotherapy of patients with pulmonary tuberculosis].
    Golyshevskaia VI; El'shanskaia MP; Akhunov ShB
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):22-8. PubMed ID: 3133915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The variability of Mycobacterium tuberculosis in patients with cavitary pulmonary tuberculosis in the course of chemotherapy.
    Khomenko AG
    Tubercle; 1987 Dec; 68(4):243-53. PubMed ID: 3138800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation and study of the morphological properties and immunogenicity of filterable forms of Mycobacterium tuberculosis].
    Khomenko AG; Golyshevskaia VI; Korolev MB; Litvinov VI; Il'ina IN
    Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):32-6. PubMed ID: 6410622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filtrable forms of mycobacteria tuberculosis.
    Khomenko AG; Golyshevskaya VI
    Z Erkr Atmungsorgane; 1984; 162(2):147-54. PubMed ID: 6429959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of the filterable forms of Mycobacterium tuberculosis and their significance in pathology].
    Golyshevskaia VI; Zemskova ZS; Korolev MB
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):23-7. PubMed ID: 6431716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
    Clancy LJ; Kelly P; O'Reilly L; Byrne C; Costello E
    Eur Respir J; 1990 Apr; 3(4):399-402. PubMed ID: 2114307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antituberculosis antibodies in patients with tuberculosis during chemotherapy].
    Stakhanov VA; Vasil'ev NA; Levi DT; Rukhamina ML
    Probl Tuberk; 2001; (5):48-50. PubMed ID: 11588965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [L forms of Mycobacterium tuberculosis and their clinico-epidemiological significance].
    Anastasatu C; Moldovan O
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(3):203-13. PubMed ID: 3001898
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of different chemotherapy regimens with pulmonary tuberculosis patients based on the data from a comprehensive bacteriological study].
    Muratov VV; Pashkov IuN; Chukanov VI
    Probl Tuberk; 1983 May; (5):34-8. PubMed ID: 6408636
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improved methods of isolating altered forms of Mycobacterium tuberculosis in patients with stable destructive changes in lung tissue].
    Golyshevskaia VI; Akhunov ShB; Bibergal' EA
    Probl Tuberk; 1987; (10):61-5. PubMed ID: 3122201
    [No Abstract]   [Full Text] [Related]  

  • 11. [The nature of bacterial secretions in patients with focal pulmonary tuberculosis].
    Il'ina TIa
    Probl Tuberk; 1974; (10):6-10. PubMed ID: 4213567
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of biological assay in the detection of "latent" bacteria release during chemotherapy].
    Posperov VV; Pashkov IuN; Lobchenko AI
    Probl Tuberk; 1982 Aug; (8):62-6. PubMed ID: 6815644
    [No Abstract]   [Full Text] [Related]  

  • 13. [The virulence of Mycobacterium tuberculosis isolated from the sputum and bronchial secretion of patients with specific forms of pulmonary tuberculosis].
    Szelerska-Twardosz H
    Pneumonol Pol; 1988 Mar; 56(3):106-10. PubMed ID: 3136445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical efficiency of combined chemotherapy of patients with progressive forms of pulmonary tuberculosis].
    Cheren'ko SO
    Lik Sprava; 2001; (1):76-80. PubMed ID: 15311700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycobacterium tuberculosis L forms in patients with pulmonary and pleural tuberculosis during antibacterial chemotherapy].
    Osiĭskiĭ IIu; Kotliar KD
    Vrach Delo; 1989 Sep; (9):55-6. PubMed ID: 2514488
    [No Abstract]   [Full Text] [Related]  

  • 17. Variability of mycobacterial population in the process of the experimental chemotherapy of tuberculosis.
    Golyshevskaya VI
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(3):263-6. PubMed ID: 3027864
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].
    Bekembaeva GS; Serikbaeva KS; Kastypkaeva DV
    Probl Tuberk Bolezn Legk; 2009; (6):13-6. PubMed ID: 19642567
    [No Abstract]   [Full Text] [Related]  

  • 20. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
    Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
    Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.